Natural history of graves’ orbitopathy after treatment-Reference-Cited by-同舟云学术

Natural history of graves’ orbitopathy after treatment

Published:2016-10-05 Issue:2 Volume:57 Page:226-233
ISSN:1355-008X
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Menconi Francesca,Leo Marenza,Sabini Elena,Mautone Teresa,Nardi Marco,Sainato Aldo,Sellari-Franceschini Stefano,Vitti Paolo,Marcocci Claudio,Marinò Michele^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/article/10.1007/s12020-016-1136-x/fulltext.html

Reference24 articles.

1. L. Bartalena, L. Baldeschi, K. Boboridis, A. Eckstein, G.J. Kahaly, C. Marcocci, P. Perros, M. Salvi, W.M. Wiersinga; European Group on Graves’ Orbitopathy (EUGOGO), The 2016 European thyroid association/European group on Graves’ orbitopathy guidelines for the management of graves’ orbitopathy. Eur. Thyroid J. 5, 9–26 (2016)

2. L. Bartalena, A. Pinchera, C. Marcocci, Management of Graves’ ophthalmopathy: reality and perspectives. Endocr. Rev. 212, 168–199 (2000)

3. C. Marcocci, M. Marinò, Treatment of mild, moderate-to-severe and very severe Graves’ orbitopathy. Best Pract. Res. Clin. Endocrinol. Metab. 26, 325–337 (2012)

4. C. Marcocci, A. Pinchera, M. Marinò, A treatment strategy for Graves’ orbitopathy. Nat. Clin. Pract. Endocrinol. Metab. 3, 430–436 (2007)

5. A.K. Eckstein, M. Plicht, H. Lax, M. Neuhäuser, K. Mann, S. Lederbogen, C. Heckmann, J. Esser, N.G. Morgenthaler, Thyrotropin receptor autoantibodies are independent risk factors for Graves’ ophthalmopathy and help to predict severity and outcome of the disease. J. Clin. Endocrinol. Metab. 91, 3464–3470 (2006)

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic factors for thyroid-stimulating immunoglobulin normalization in moderate-to-severe Graves’ orbitopathy: a 36-month longitudinal study;BMC Ophthalmology;2024-08-21

2. Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves’ Orbitopathy;Ophthalmology and Therapy;2024-02-20

3. Evaluation of disease-specific quality of life and its influencing factors in Bulgarian patients with Graves’ orbitopathy;International Ophthalmology;2024-02-12

4. Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors;Ophthalmic Plastic & Reconstructive Surgery;2023-12

5. Current concepts regarding Graves’ orbitopathy;Journal of Internal Medicine;2022-06